GAO participation in FDA foreign plant inspections under consideration.
This article was originally published in The Tan Sheet
Executive Summary
GAO FOREIGN INSPECTION PARTICIPATION UNDER DISCUSSION WITH FDA in light of a recent General Accounting Office report on "Improvements Needed in the Foreign Drug Inspection Program," presented to House Commerce/Oversight Subcommittee Chairman Joe Barton (R-Tex.) in March and released April 24. The subcommittee tentatively had planned a hearing on the report for April but has postponed the session pending further research, including examination of possible GAO participation in foreign drug manufacturing plant inspections.